Skip to main content
. 2020 May 18;8(2):233. doi: 10.3390/vaccines8020233

Figure 2.

Figure 2

Potential averted incidence of invasive pneumococcal disease (IPD, children <1 years old) in targeted regions in scenarios for multi-dose PCV13 and PCV10 A.